Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: An international multiobserver study

Journal of Thoracic Oncology

Volumn 9, Issue 9, 2014, Pages 1354-1362

  Thunnissen, Erik ^a   Noguchi, Masayuki ^b   Aisner, Seena ^c   Beasley, Mary Beth ^d   Brambilla, Elisabeth ^e   Chirieac, Lucian R ^f   Chung, Jin Haeng ^g   Dacic, Sanja ^h   Geisinger, Kim R ^i,j   Hirsch, Fred R ^k   Ishikawa, Yuichi ^l   Kerr, Keith M ^m   Lantejoul, Sylvie ⁿ   Matsuno, Yoshiro ^o   Minami, Yuko ^p   Moreira, Andre L ^q   Pelosi, Giuseppe ^r   Petersen, Iver ^s   Roggli, Victor ^t   Travis, William D ^p   Wistuba, Ignacio ^u   Yatabe, Yasushi ^v   Dziadziuszko, Rafal ^w   Witte, Birgit ^a   Tsao, Ming Sound ^x   Nicholson, Andrew G ^y   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Faculty of Medicine   (Japan)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e HÔPITAL MICHALLON   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Seoul National University Bundang Hospital   (South Korea)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ Piedmont Pathology Associates   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^l CANCER INSTITUTE   (Japan)

^m ABERDEEN ROYAL INFIRMARY   (United Kingdom)

ⁿ INSTITUT ALBERT BONNIOT   (France)

^o Tsukuba Medical   (Japan)

^p UNIVERSITY OF TSUKUBA   (Japan)

^q MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^r UNIVERSITY OF MILAN   (Italy)

^s Institut für Pathologie Diakoniekrankenhaus Rotenburg W   (Germany)

^t DUKE UNIVERSITY MEDICAL CENTER   (United States)

^u UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^v AICHI CANCER CENTER HOSPITAL   (Japan)

^w MEDICAL UNIVERSITY OF GDANSK   (Poland)

^x UNIVERSITY HEALTH NETWORK   (Canada)

^y ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Non small cell lung cancer; Pathology; Reproducibility

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CARCINOMA; CELL JUNCTION; CELL VACUOLE; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPHOCYTE; LYMPHOEPITHELIAL LIKE CARCINOMA; PATHOLOGIST; PILOT STUDY; POORLY DIFFERENTIATED LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; REPRODUCIBILITY; SARCOMATOID CARCINOMA; SENSITIVITY AND SPECIFICITY; SPINDLE CELL; STROMA; TISSUE SECTION; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONECTOMY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84906261786     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000264     Document Type: Article

References (27)

1. Travis W, Brambilla E, Muller-Hermelink H (Eds.), WHO Classification of Tumours, Pathology and Genetics: Tumors of the Lung, Pleura Thymus and Heart. Lyon: IARC Press LYON, 2004.
2. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-285.
3. Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 2012;25:1574-1583.
4. Hanai A, Whittaker JS, Tateishi R, Sobin LH, Benn RT, Muir CS. Concordance of histological classification of lung cancer with special reference to adenocarcinoma in Osaka, Japan, and the North-West Region of England. Int J Cancer 1987;39:6-9.
5. Feinstein AR, Gelfman NA, Yesner R. Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis 1970;101:671-684.
6. Colby TV, Tazelaar HD, Travis WD, Bergstralh EJ, Jett JR. Pathologic review of the Mayo Lung Project cancers [corrected]. Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group? Cancer 2002;95:2361-2365.
7. Grilley-Olson JE, Hayes DN, et al. Validation of interobserver agreement in lung cancer assessment hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer - the 2004 World Health Organization Classification and Therapeutically Relevant Subsets. Arch Pathol Lab Med 2013;137:32-40.
8. Thunnissen E, Boers E, Heideman DA, et al. Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma. Virchows Arch 2012;461:629-638.
9. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
10. Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985;16:569-579.
11. Stanley KE, Matthews MJ. Analysis of a pathology review of patients with lung tumors. J Natl Cancer Inst 1981;66:989-992.
12. Tsuta K, Tanabe Y, Yoshida A, et al. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol 2011;6:1190-1199.
13. Rossi G, Mengoli MC, Cavazza A, et al. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Virchows Arch 2014;464:61-68.
14. Rossi G, Tiseo M, Cavazza A, Colby T V. Is immunohistochemistry always required to diagnose lung cancer? Adv Anat Pathol 2013;20:327-333.
15. Hwang DH, Szeto DP, Perry AS, et al. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. Arch Pathol Lab Med 2014;138:626-635.
16. Monica V, Ceppi P, Righi L, et al. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 2009;22:709-717.
17. Pardo J, Martinez-Penuela AM, Sola JJ, et al. Large cell carcinoma of the lung: an endangered species? Appl Immunohistochem Mol Morphol 2009;17:383-392.
18. Yesner R, Gerstl B, Auerbach O. Application of the World Health Organization Classification of Lung Carcinoma to Biopsy Material. Ann Thorac Surg 1965;10:33-49.
19. Rekhtman N, Paik PK, Arcila ME, et al. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin Cancer Res 2012;18:1167-1176.
20. Brambilla E, Moro D, Veale D, et al. Basal Cell (Basaloid) Carcinoma of the Lung : A new Morphologic and Phenotypic entity With Separate Prognostic Significance. Hum Pathol 1992;23:993-1003.
21. Moro-Sibilot D, Lantuejoul S, et al. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J 2008;31:854-859.
22. Wang LC, Wang L, Kwauk S, et al. Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung. J Cardiothorac Surg 2011;6:10.
23. Kim DJ, Kim KD, Shin DH, Ro JY, Chung KY. Basaloid carcinoma of the lung: a really dismal histologic variant? Ann Thorac Surg 2003;76:1833-1837.
24. Maleki Z. Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology. Diagn Cytopathol 2011;39:159-167.
25. Crapanzano JP, Loukeris K, Borczuk AC, Saqi A. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features. Diagn Cytopathol 2010;39:92-100.
26. Kim MJ, Ha SY, Kim NR, Cho HY, Chung DH, Kim GY. Aspiration cytology features of pulmonary basaloid carcinoma. Cytopathology 2009;20:336-339.
27. Yamada S, Noguchi H, Nabeshima A, et al. Basaloid carcinoma of the lung associated with central cavitation: a unique surgical case focusing on cytological and immunohistochemical findings. Diagn Pathol 2013;7:175.